Earlier in June, a piece of news about the decriminalization of psychedelic mushrooms in Oakland came in. According to the new legislation, the authorities would no longer arrest individuals for possessing a certain amount of psilocybin substances.
The news was believed to be a big breakthrough but saw a flurry of activity between the proponents and the opponents. The latter group put forward a list of consequences that could result with the usage of psychedelic mushrooms mainly pointing towards cognition impairment.
However, the former group had something more interesting to argue. The biggest proposition put forward in favor was that psilocybin may potentially be beneficial for a number of health reasons!
That being said, there has been a new update in the possible advantages of mushrooms and other psychedelic drugs like MDMA. Scientists are now just one step from concluding that both can possibly be used to treat a number of chronic mental illnesses such as anxiety and depression.
The findings are currently underway, and it would not be long before a consensus is reached.
Psychedelic Drugs to Treat PTSD
The study was co-authored by three Canadian scientists who looked to investigate their relevant concerns. Their main aim was to find whether psychedelic drugs have any effect whatsoever on treating mental ailments.
For that, around 30 people who had Post-Traumatic Stress Disorder (PTSD) volunteered for their experiment. The condition had prolonged for months and even years in some circumstances. Accordingly, the participants were randomly assigned two dosages of MDMA: 100mg and 125mg respectively. The therapy session continued twice every month for the next 12 months.
For an accurate comparison, a placebo effect was also put into place
Once the research ended, the comparative scores were assessed, and findings were documented. On an analysis further at the results, scientists gave positive remarks on the effect of psychedelic therapy instigated by the use of MDMA.
After the 12-month trial period, nearly half of the participants had witnessed a more than 30% decline in their scores. Although small variations in the intensity of the symptoms were recorded for the participants.
Suffice enough to say, the Canadian research showed that given treatment through MDMA and other psychedelic drugs, we can expect a considerable reduction in PTSD symptoms.
Why is that the case?
The next task entailed finding the possible explanations for the phenomena recorded. A number of arguments were put forward which make all the more sense in the field of neuropsychiatry.
In cases where a person feels depressed as in the case with PTSD, there occurs a certain hormonal imbalance. This imbalance, in turn, becomes the reason for mood disruption and the negativity that prevails in the mind.
However, psychedelic drugs like MDMA and Psilocybin Mushrooms are found to reverse the action. Both revive the action of the brain bringing the reduced hormonal secretion back to the normal level. In a way, this results in a flow of positive emotions.
But there are still some essential guidelines to consider before we proceed with mass usage of psychedelic drugs.
Firstly, the studies conducted on the substances are in their initial stages. Even the scientists conclude that further research is needed to arrive at a more concrete conclusion. Although the trend has proven to be positive, we should wait sometime before indulging in mass distribution.
The other thing to note is that the amount of drug ingestion was controlled. Excessive intake can be harmful and lead to severe health consequences.